Intermap Tech Corp. (IMP.TO) 0.20 $IMP.TO
Intermap Technologies 2014 Second Quarter Conference Call Notice
CNW Group - Wed Jul 23, 3:14PM CDT
(TSX: IMP) - Intermap Technologies Corporation issued notice today that it will release its 2014 second quarter financial results following the close of markets on Monday August 11, 2014.
Intermap Adopts Advance Notice By-Law
CNW Group - Wed Jul 16, 4:30PM CDT
Intermap Technologies (TSX:IMP), (ITMSF:BB), a leading provider of location-based solutions, announced today that its Board of Directors has approved the adoption of an advance notice by-law (the "Advance Notice By-law"
, which requires advance notice to Intermap in circumstances where nominations of persons for election to the Board are made by shareholders other than pursuant to a requisition of a meeting made pursuant to the provisions of the Business Corporations Act (Alberta) ("ABCA" or a shareholder proposal made pursuant to the provisions of the ABCA.
Intermap Technologies introduces GeoPro Server Software Application
M2 - Fri Jun 27, 9:17AM CDT
Provider of location-based solutions Intermap Technologies (TSX:IMP)(ITMSF:BB) announced on Friday the commercial availability of GeoPro Server, purpose-built for turning big data into smart decisions.
Intermap's GeoPro Server(TM) Software Application Introduced into the Geospatial Market
CNW Group - Fri Jun 27, 7:29AM CDT
- Centerpiece of Intermap's Orion PlatformTM Targets $3.2 Billion Geospatial Software Industry -
Intermap's GeoPro Server™ Software Application Introduced into the Geospatial Market
PR Newswire - Fri Jun 27, 7:29AM CDT
Centerpiece of Intermap's Orion Platform™ Targets $3.2 Billion Geospatial Software Industry -
Intermap Signs InsitePro(TM) Software Agreement with Top 10 Global Reinsurer
CNW Group - Tue Jun 10, 5:20AM CDT
- Key Components of the Intermap Orion PlatformTM Licensed -
Intermap Signs InsitePro™ Software Agreement with Top 10 Global Reinsurer
PR Newswire - Tue Jun 10, 5:20AM CDT
Key Components of the Intermap Orion Platform™ Licensed -
Intermap Technologies Reports 2013 Fourth Quarter and Year-End Financial Results
CNW Group - Mon Mar 17, 3:00PM CDT
(TSX: IMP) - Intermap Technologies Corporation ("Intermap" or the "Company" today reported financial results for the fourth quarter and year ended December 31, 2013. A conference call will be held today, March 17(th), at 4:30 p.m. Eastern Time to discuss the results.
Intermap Technologies 2013 Fourth Quarter Conference Call Notice
CNW Group - Thu Feb 27, 8:10AM CST
(TSX: IMP) - Intermap Technologies Corporation issued notice today that it will release its 2013 fourth quarter financial results following the close of markets on Monday, March 17, 2014.
Proformative Announces Winners of Inaugural ProformaTECH 2014 Awards for Excellence
PR Newswire - Thu Feb 13, 10:00AM CST
Proformative, the pioneering leader in Enterprise Social Procurement(TM) for the office of the CFO, today announced the winners of the company's first annual ProformaTECH 2014 Awards for Excellence, designed to honor visionary CFOs and their teams who have fully embraced technology as a vehicle for driving breakthrough performance. Winners in three categories will be recognized during the closing presentation of ProformaTECH 2014--the premier technology conference for senior corporate finance-related executives--which is being held today at the Venetian Las Vegas.
Intermap Completes US$5.0 Million Convertible Debt Financing
CNW Group - Fri Feb 07, 3:00PM CST
(TSX: IMP) - Intermap Technologies Corporation ("Intermap" or the "Company", is pleased to announce that on February 7, 2014, it completed a previously announced private placement convertible debt financing for aggregate proceeds of US$5,000,000 (the "Debt Financing".
CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Phase 2 Trial Evaluating Pacritinib for Patients with Relapsed FLT3 Positive Acute Myeloid Leukemia
PR Newswire - Thu Jan 30, 12:30AM CST
Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis. Pacritinib is an oral JAK2/FLT3 inhibitor that has demonstrated encouraging activity in preclinical models of AML with mutated FLT3 gene, including additional FLT3 mutations that confer resistance to other targeted FLT3 agents. The trial is being conducted by the AML Working Group of the National Cancer Research Institute Haematological Oncology Study Group in Acute Myeloid Leukemia (AML) and high risk Myelodysplastic Syndrome (MDS) under the sponsorship of Cardiff University and supported by Cancer Research UK. The trial management group is lead by Professor Alan K. Burnett, Head of Haematology in the Department of Medical Genetics, Haematology and Pathology at the School of Medicine at Cardiff University.
Iberdrola S.A. Awarded 300 MW Combined-Cycle Power Plant Project in Baja California, Mexico
PR Newswire - Fri Jan 24, 6:10AM CST
Iberdrola USA parent company, Iberdrola S.A. has been awarded a contract for the construction and operation of the 300 megawatt (MW) Baja California III combined-cycle power plant in Mexico. Work on the $270 million plant and associated facilities will begin in April 2014 with commercial operation planned for August 2016.
Intermap Technologies Announces US$5.0 Million Convertible Debt Financing
CNW Group - Fri Jan 24, 4:30AM CST
Expansion capital accelerates the development and market introduction of Intermap's RiskProTM and GeoProTM 3D Business Intelligence software products
Intermap's NEXTMap® World 30(TM) Sales Surpass $1 Million on Demand Growth in 2013
CNW Group - Fri Jan 10, 7:45AM CST
- World 30 Sales Year-Over-Year Grow Over 15 Times in 2013 -
Intermap's NEXTMap® World 30™ Sales Surpass $1 Million on Demand Growth in 2013
PR Newswire - Fri Jan 10, 7:45AM CST
World 30 Sales Year-Over-Year Grow Over 15 Times in 2013 -
USD Outlook Weighed by Disinflation- JPY Unphased by BoJ
David Song, Currency Analyst - DailyFX - Fri Dec 20, 1:03PM CST
Talking Points:
Intermap Technologies 2014 Second Quarter Conference Call Notice
CNW Group - Wed Jul 23, 3:14PM CDT
(TSX: IMP) - Intermap Technologies Corporation issued notice today that it will release its 2014 second quarter financial results following the close of markets on Monday August 11, 2014.
Intermap Adopts Advance Notice By-Law
CNW Group - Wed Jul 16, 4:30PM CDT
Intermap Technologies (TSX:IMP), (ITMSF:BB), a leading provider of location-based solutions, announced today that its Board of Directors has approved the adoption of an advance notice by-law (the "Advance Notice By-law"
, which requires advance notice to Intermap in circumstances where nominations of persons for election to the Board are made by shareholders other than pursuant to a requisition of a meeting made pursuant to the provisions of the Business Corporations Act (Alberta) ("ABCA" or a shareholder proposal made pursuant to the provisions of the ABCA. Intermap Technologies introduces GeoPro Server Software Application
M2 - Fri Jun 27, 9:17AM CDT
Provider of location-based solutions Intermap Technologies (TSX:IMP)(ITMSF:BB) announced on Friday the commercial availability of GeoPro Server, purpose-built for turning big data into smart decisions.
Intermap's GeoPro Server(TM) Software Application Introduced into the Geospatial Market
CNW Group - Fri Jun 27, 7:29AM CDT
- Centerpiece of Intermap's Orion PlatformTM Targets $3.2 Billion Geospatial Software Industry -
Intermap's GeoPro Server™ Software Application Introduced into the Geospatial Market
PR Newswire - Fri Jun 27, 7:29AM CDT
Centerpiece of Intermap's Orion Platform™ Targets $3.2 Billion Geospatial Software Industry -
Intermap Signs InsitePro(TM) Software Agreement with Top 10 Global Reinsurer
CNW Group - Tue Jun 10, 5:20AM CDT
- Key Components of the Intermap Orion PlatformTM Licensed -
Intermap Signs InsitePro™ Software Agreement with Top 10 Global Reinsurer
PR Newswire - Tue Jun 10, 5:20AM CDT
Key Components of the Intermap Orion Platform™ Licensed -
Intermap Technologies Reports 2013 Fourth Quarter and Year-End Financial Results
CNW Group - Mon Mar 17, 3:00PM CDT
(TSX: IMP) - Intermap Technologies Corporation ("Intermap" or the "Company"
today reported financial results for the fourth quarter and year ended December 31, 2013. A conference call will be held today, March 17(th), at 4:30 p.m. Eastern Time to discuss the results. Intermap Technologies 2013 Fourth Quarter Conference Call Notice
CNW Group - Thu Feb 27, 8:10AM CST
(TSX: IMP) - Intermap Technologies Corporation issued notice today that it will release its 2013 fourth quarter financial results following the close of markets on Monday, March 17, 2014.
Proformative Announces Winners of Inaugural ProformaTECH 2014 Awards for Excellence
PR Newswire - Thu Feb 13, 10:00AM CST
Proformative, the pioneering leader in Enterprise Social Procurement(TM) for the office of the CFO, today announced the winners of the company's first annual ProformaTECH 2014 Awards for Excellence, designed to honor visionary CFOs and their teams who have fully embraced technology as a vehicle for driving breakthrough performance. Winners in three categories will be recognized during the closing presentation of ProformaTECH 2014--the premier technology conference for senior corporate finance-related executives--which is being held today at the Venetian Las Vegas.
Intermap Completes US$5.0 Million Convertible Debt Financing
CNW Group - Fri Feb 07, 3:00PM CST
(TSX: IMP) - Intermap Technologies Corporation ("Intermap" or the "Company"
, is pleased to announce that on February 7, 2014, it completed a previously announced private placement convertible debt financing for aggregate proceeds of US$5,000,000 (the "Debt Financing". CTI Announces United Kingdom National Cancer Research Institute AML Cooperative Group Phase 2 Trial Evaluating Pacritinib for Patients with Relapsed FLT3 Positive Acute Myeloid Leukemia
PR Newswire - Thu Jan 30, 12:30AM CST
Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced the initiation of an international cooperative group Phase 2 clinical trial of pacritinib in adult patients with relapsed acute myeloid leukemia (AML) with mutations of the FLT3 gene. Mutation of the FLT3 gene is found in approximately one-third of AML patients and is an independent risk factor for poor prognosis. Pacritinib is an oral JAK2/FLT3 inhibitor that has demonstrated encouraging activity in preclinical models of AML with mutated FLT3 gene, including additional FLT3 mutations that confer resistance to other targeted FLT3 agents. The trial is being conducted by the AML Working Group of the National Cancer Research Institute Haematological Oncology Study Group in Acute Myeloid Leukemia (AML) and high risk Myelodysplastic Syndrome (MDS) under the sponsorship of Cardiff University and supported by Cancer Research UK. The trial management group is lead by Professor Alan K. Burnett, Head of Haematology in the Department of Medical Genetics, Haematology and Pathology at the School of Medicine at Cardiff University.
Iberdrola S.A. Awarded 300 MW Combined-Cycle Power Plant Project in Baja California, Mexico
PR Newswire - Fri Jan 24, 6:10AM CST
Iberdrola USA parent company, Iberdrola S.A. has been awarded a contract for the construction and operation of the 300 megawatt (MW) Baja California III combined-cycle power plant in Mexico. Work on the $270 million plant and associated facilities will begin in April 2014 with commercial operation planned for August 2016.
Intermap Technologies Announces US$5.0 Million Convertible Debt Financing
CNW Group - Fri Jan 24, 4:30AM CST
Expansion capital accelerates the development and market introduction of Intermap's RiskProTM and GeoProTM 3D Business Intelligence software products
Intermap's NEXTMap® World 30(TM) Sales Surpass $1 Million on Demand Growth in 2013
CNW Group - Fri Jan 10, 7:45AM CST
- World 30 Sales Year-Over-Year Grow Over 15 Times in 2013 -
Intermap's NEXTMap® World 30™ Sales Surpass $1 Million on Demand Growth in 2013
PR Newswire - Fri Jan 10, 7:45AM CST
World 30 Sales Year-Over-Year Grow Over 15 Times in 2013 -
USD Outlook Weighed by Disinflation- JPY Unphased by BoJ
David Song, Currency Analyst - DailyFX - Fri Dec 20, 1:03PM CST
Talking Points:
